|
UnitedHealth’s Rough Q1, AI Bias, and RPM in the Hot Seat April 21, 2025
|
|
|
|
Together with
|
|
|
“The very best doctors and nurses have always had a rare mix of experience, expertise, empathy and emotional intelligence. But before AI, that secret sauce was near-impossible to bottle up and scale. That’s exactly what we’re doing now.”
|
Included Health CEO Owen Tripp
|
|
|
The Peterson Center on Healthcare is back with another report that doesn’t mince words when it comes to remote patient monitoring: “RPM reimbursement in Medicare is misaligned with the clinical value of these tools.”
The report synthesized Peterson’s past evaluations of diabetes, hypertension, and musculoskeletal solutions, which encompassed the trio of conditions associated with the highest spending and utilization for remote monitoring services.
Although only ~1% of Medicare patients are in RPM programs, utilization has grown exponentially since the start of the pandemic.
- There’s been a tenfold increase in Medicare patients using RPM services from 2019 to 2023 (44k to over 451k patients).
- Medicare expenditures for RPM skyrocketed from $6.8M to $194.5M over the same time period.
There’s also been a steady rise in long-term monitoring, even though research suggests most of RPM’s benefits accrue within the first few months.
- The average RPM episode duration was just 1.7 months in 2019, jumping to 5.2 months by 2023. Over 22% of RPM episodes now last over nine months.
- There’s currently no limit on how long providers can use RPM for a specific patient, meaning they can be reimbursed “on a monthly basis in perpetuity for anyone with a diagnosed chronic condition, even if they are already well-managed.”
PCH offered three recommendations to policymakers to combat these issues:
- Base coverage and reimbursement on proven clinical value for different conditions.
- End indefinite billing practices for “forever codes” that encourage waste.
- Improve data collection to enable evidence-based decision making about the value and use of remote monitoring.
The Takeaway
As providers adopt new technologies that extend care beyond the walls of the hospital, aligning incentives with high-value care sounds like an obvious approach to reimbursement, but PCH’s report makes it clear that current policies need an overhaul if they’re going to maximize the effectiveness of RPM programs.
|
|
How Navina Empowers Privia Health Physicians to Excel in VBC
The shift to value-based care comes with many challenges, but AI can make a powerful difference. At Privia Health, Navina helped improve HCC coding accuracy while reducing the manual burden on physicians and empowering them to focus on patient care – without being distracted by administrative responsibilities. Read on to learn the practical lessons from Privia Health’s experience leveraging Navina’s AI to excel in value-based care.
|
|
The First 30 Days: What to Expect With AI
Implementing AI documentation tools promises significant benefits, but how do you ensure a smooth transition? Playback Health has you covered with this comprehensive 30-day roadmap outlining what to expect, industry best practices, and its own proven implementation approach.
|
|
- UnitedHealth Reports Rough Q1: UnitedHealth Group just posted its worst trading day in company history after reporting a double-miss on revenue growth and EPS during Q1. United’s first quarter meltdown was centered around both its UnitedHealthcare insurance arm (which is struggling to contain costs in Medicare Advantage and saw utilization climb even higher) and Optum services division (which is grappling with declining profitability in the wake of recent policy changes). Although the biggest healthcare cyberattack of all time and Luigi Mangione weren’t enough to keep UNH stock down, a slashed outlook for 2025 sent shares nosediving 22%.
- AI Sociodemographic Bias: New research in Nature Medicine shows that AI frequently recommends different treatments for identical conditions based solely on patient demographics. Mount Sinai researchers evaluated nine LLMs on 1,000 ED cases, with each case presented in 32 variations (31 sociodemographic groups plus a control). The LLMs had a tendency to escalate care recommendations – particularly for mental health evaluations – based on sociodemographic factors. High-income patients were more frequently recommended advanced diagnostics like CT scans and MRIs, while low-income patients were often advised to forgo further testing.
- Zoom Workplace for Frontline: Zoom officially debuted Zoom Workplace for Frontline, a mobile-first solution purpose-built “to unlock agentic Zoom AI Companion skills for all frontline workers.” Key features include on-shift communication (auto-generated chat groups, push-to-talk functionality), work management capabilities (shift swapping, shift summaries), and the Zoom AI Companion (AI-generated shift discussion summaries, attendance reports, and task reports).
- Digital Cognitive Health Screening in Primary Care: A study published in JMIR showed that digital cognitive assessments could help close a critical gap in primary care: only half of patients over age 60 receive cognitive assessments during routine visits. UMass researchers had 150 patients complete Linus Health’s CCE tablet-based cognitive impairment assessment before their regularly scheduled primary care appointments. CCE flagged 40 patients for borderline cognitive impairment, and seven tested positive, prompting PCPs to place 84 orders for follow-up lab tests or referrals to neurology and neuropsychology within 20 days.
- Nabla + Altera Paragon Denali: Nabla’s ambient AI assistant is now generally available for Paragon Denali EHR clients, who practice primarily in rural, critical access, and community health hospitals. The integration lets clinicians choose from multiple note templates while having Nabla naturally adapt to their documentation styles, allowing them to automatically generate clinical notes within native EHR workflows in under five seconds and reduce documentation burden by an expected average of two hours per day.
- At-Home Saliva Test for Prostate Cancer: A new study out of the Institute of Cancer Research suggests that an at-home saliva test is better at predicting prostate cancer risk than standard blood tests. The saliva test was used to calculate the polygenic risk score (PRS) of over 6,000 men between the age of 55 and 69 based on 130 gene variants linked to prostate cancer. After performing an MRI and prostate biopsy on the men with the highest 10% of PRS, 40% were diagnosed with prostate cancer, compared to just 25% of men who are diagnosed following blood tests that indicate a high PSA level.
- Array CareConnect Launch: Array Behavioral Care launched its comprehensive CareConnect platform to link mental health treatments across settings. CareConnect unites Array’s three core product families to equip healthcare orgs with a scalable way to deliver measurement-based behavioral treatments at every stage of the patient journey, including Array OnDemand Care (acute psychiatric crisis and stabilization), Array Community Care (virtual mental healthcare for outpatient clinics), and Array AtHome (ongoing psychiatry and therapy services for referred and discharged patients).
- Plummeting ED Reimbursement: A recent RAND report found that declining reimbursement and increases in claim denials are putting the viability of hospital-based emergency care in the U.S. at risk. The report showed that Medicare and Medicaid reimbursements to ED physicians each fell by 3.8% from 2018 to 2022 after adjusting for inflation. ED physicians saw even steeper declines from private payors over the same period, with a 10.9% decrease for commercial in-network visits and a 47.7% fall off for commercial out-of-network visits.
- Hello Heart, Hello Outcomes: According to an independent study, Hello Heart’s digital heart health program for self-insured employers could significantly reduce medical costs per member per year. The study found that employers experienced an average reduction of $1,434 PMPY for Hello Heart participants compared to matched non-participants, with the greatest reductions seen in members with cardiovascular disease ($15,193 PMPY), diabetes ($5,343 PMPY), and hypertension ($2,499 PMPY).
- TytoCare Rhonchi Clearance: TytoCare just became the world’s first virtual care company to receive FDA clearance for AI-based detection of all three major abnormal lung sounds: wheezes, crackles, and rhonchi. By combining a smart digital stethoscope with a proprietary database of 1.8M lung sound recordings, the Tyto Insights for Lung Sounds suite can now analyze the three most clinically significant abnormal lung sounds in real-time and flag abnormalities for clinical review – directly within its Home Smart Clinic and Pro Smart Clinic solutions.
|
|
2025 State of Payer Enrollment & Credentialing
With increasing costs and shifting regulations, outdated processes won’t cut it. Medallion’s new report breaks down the biggest challenges, emerging trends, and how automation is transforming the landscape. Get the insights you need – read the full report today.
|
|
Meet Nabla at Becker’s Annual Meeting
Looking for both ambient note generation and dictation – in one AI assistant? Nabla is the only AI assistant that does both, seamlessly. Visit booth 10F at Becker’s Annual Meeting to see it in action and discover how Nabla is changing the way care teams work.
|
|
- Simplify RPM & Maximize Patient Engagement: Engaging patients at critical moments is essential for success. With Withings Health Nudges feature, care teams can send tailored messages to the screen of the blood pressure monitor— offering personalized support when they need it most.
- Create Efficient Primary Care Access With K Health’s Clinical AI: Keeping up with patient access feels like a losing battle? Hartford HealthCare, Cedars-Sinai, and Hackensack Meridian Health found a new approach. K Health partners with health systems to scale high-quality 24/7 primary care access without sacrificing quality. Learn how K Health’s peer-reviewed clinical AI and Virtualist model are transforming how leading systems deliver care.
- Leading Global Cancer Center Chooses Abridge: During a rigorous pilot study, Memorial Sloan Kettering Cancer Center clinicians in several oncological specialties – including hematology, head and neck surgery, and neurology – found that Abridge accurately captured the complexity of oncology terminology, including disease names, treatment names, and drug names. Abridge will be scaled across the organization in 2025 and 2026. Learn more.
|
|
|
|
|